Charlotte Kromer

Federal Institute for Risk Assessment

Papers

1

Total Citations

62

H-Index

1

About

Charlotte Kromer is a leading researcher in inhalation toxicology, with a focus on understanding how airborne particulates—from cigarette smoke and e-cigarette vapors to environmental pollutants—damage lung tissue. Her major contribution lies in advancing in vitro air-liquid interface (ALI) culture models, particularly lung-on-chip technologies, which offer more physiologically relevant alternatives to traditional animal testing. Her highly cited 2021 perspective piece (62 citations) critically examines the challenges and opportunities in this field, highlighting how these models can better replicate human respiratory exposure. Kromer’s work is pivotal in bridging the gap between laboratory research and real-world inhalation risks, providing tools to assess the toxicity of smoking and vaping products with greater accuracy. Her research not only deepens our understanding of pulmonary health but also supports regulatory science and safer product design. For students and researchers, Kromer’s innovative use of microfluidic platforms represents a transformative step in toxicology, offering a humane, precise, and scalable approach to studying lung disease and exposure-related harm.

Research Focus

Key Achievements

1
H-Index
1
Papers
62
Total Citations
62
Avg Citations/Paper
🏆 Most Cited Paper
Advances in Smoking Related In Vitro Inhalation Toxicology: A Perspective Case of Challenges and Opportunities from Progresses in Lung-on-Chip Technologies
62 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Federal Institute for Risk Assessment

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago